Clinical Trial Update: Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating everolimus in combination with chemotherapy for metastatic stomach or esophageal cancer; results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagus
• Adenocarcinoma of the Gastroesophageal Junction
• Diffuse Adenocarcinoma of the Stomach
• Esophageal Cancer
• Gastric Cancer
• Intestinal Adenocarcinoma of the Stomach
• Mixed Adenocarcinoma of the Stomach

Drugs mentioned

• Everolimus (Afinitor) (everolimus)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-31